George, J., Ma, X., Kadamberi, I. P., Nair, A., Mittal, S., Hashemi, E., Kumar, S., Singh, M., Geethadevi, A., Pradeep, M., Nair, A., Tsaih, S., Jorns, J. M., Malarkannan, S., Dietlein, F., Lin, C., Pradeep, S., Chaluvally-Raghavan, P. (2026). Single-cell transcriptomics reveals FXR1 as an actionable target for siRNA therapy in ovarian cancer. Nature Communications. https://doi.org/10.1038/s41467-026-71468-y